Skip to main content

Procaine

ADVERTISEMENT
Identification
Molecular formula
C13H20N2O2
CAS number
59-46-1
IUPAC name
3-(dimethylamino)propyl 2-(2-phenylethyl)benzoate
State
State

At room temperature, Procaine is typically in a solid state due to its crystalline form.

Melting point (Celsius)
61.00
Melting point (Kelvin)
334.20
Boiling point (Celsius)
411.70
Boiling point (Kelvin)
684.90
General information
Molecular weight
236.31g/mol
Molar mass
236.3110g/mol
Density
1.0930g/cm3
Appearence

Procaine is typically found in the form of a white or slightly off-white crystalline powder. It is odorless, which makes it ideal for its use in medical applications. The compound may appear as a solution when dissolved for injections.

Comment on solubility

Solubility of 3-(dimethylamino)propyl 2-(2-phenylethyl)benzoate

The solubility of the compound 3-(dimethylamino)propyl 2-(2-phenylethyl)benzoate exhibits interesting characteristics that are worth exploring. This compound, due to its unique structure which includes both hydrophobic and hydrophilic components, demonstrates varying degrees of solubility depending on the solvent used.

Key Factors Influencing Solubility:

  • Polar vs. Nonpolar Solvents: Generally, organic compounds with aromatic rings tend to be more soluble in nonpolar solvents like hexane or toluene, while the polar modifications, such as the dimethylamino group, may enhance solubility in polar solvents like ethanol or water.
  • Temperature: Increased temperature can also improve solubility, as higher thermal energy helps overcome intermolecular forces.
  • pH Levels: The solubility can vary significantly with pH, particularly due to the presence of the dimethylamino functional group which can become protonated in acidic conditions, potentially increasing its solubility in aqueous solutions.

In summary, the solubility of 3-(dimethylamino)propyl 2-(2-phenylethyl)benzoate is nuanced and highly dependent on a combination of solvent type, temperature, and pH. It is essential to conduct solubility tests under varied conditions to fully understand its potential applications and behaviors in various environments.

Interesting facts

Exploring 3-(Dimethylamino)propyl 2-(2-phenylethyl)benzoate

3-(Dimethylamino)propyl 2-(2-phenylethyl)benzoate is a compound that bridges the gap between organic chemistry and pharmaceuticals. Its multifaceted structure allows it to participate in various chemical reactions and biological activities, making it a compound of interest in research and medicinal chemistry.

Key Features

  • Pharmacological Potential: This compound belongs to a class of compounds explored for their potential as pharmaceutical agents. The dimethylamino group can enhance the solubility and bioavailability of drugs, potentially enabling better therapeutic effectiveness.
  • Structured Complexity: The combination of a benzoate moiety with a propyl chain and a phenethyl group contributes to a complex three-dimensional shape. This configuration is often crucial in determining how the compound interacts with biological targets.
  • Synthetic Applications: Chemists appreciate such compounds for their utility in drug synthesis and development. They serve as intermediates or lead compounds for further modifications and innovations in drug design.
  • Intermolecular Interactions: The compound's ability to engage in intermolecular forces can lead to interesting solvation behaviors. These forces might dictate how the compound behaves in physiological environments.

Moreover, 3-(dimethylamino)propyl 2-(2-phenylethyl)benzoate stands as a testament to the beauty of organic synthesis. As students and researchers dive deeper into the realms of medicinal chemistry, it serves as a reminder of the critical importance of understanding structure-function relationships in developing contemporary therapies.

In summary, this compound exemplifies the intricacies of organic chemistry and its profound impact on pharmaceuticals and drug design. It’s not just a chemical formula; it represents a world of endless possibilities in the quest for new medicinal breakthroughs.